Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (88K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Greatorex, J.
Right arrow Articles by Lever, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greatorex, J.
Right arrow Articles by Lever, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 2919-2924

Footnote

Sequences involved in the dimerisation of human T cell leukaemia virus type-1 RNA

Sequences involved in the dimerisation of human T cell leukaemia virus type-1 RNA Jane S. Greatorex , Valerie Laisse 1 , Marie-Christine Dokhelar 1 and Andrew M. L. Lever*

Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, UK and 1 Institut Gustav Roussy, Villejuif Cedex, France

Received April 24, 1996; Revised and Accepted June 11, 1996

ABSTRACT

The formation of a genomic RNA dimer appears to be a critical step in the life cycle of all retroviruses. To investigate the site and nucleotide interactions involved in this process, a 531 bp DNA fragment encompassing sequences up- and downstream of the splice donor in human T cell leukaemia virus type 1 (HTLV-1) was inserted into a plasmid vector under the control of the SP6 promoter. RNA transcripts generated in vitro from this template formed dimers which could be dissociated by heating at 60-80 oC for 3 min. The physical properties of the dimeric RNA were not consistent with either Watson-Crick base pairing or guanine tetrad formation as being solely responsible for the interaction. Deletion mutagenesis identified a 32 nt sequence required for dimerisation. Computer modelling was carried out in order to identify putative RNA secondary structures within this essential region. A stem-loop structure was identified, the stem of which was conserved among different sequenced isolates of HTLV-1. This sequence also contains a 15 nt palindrome. We sought by disruptive and compensatory mutagenesis to define the possible roles of these two structures in dimer linkage.

INTRODUCTION

Retroviruses have a diploid RNA genome. In the 1970s electron microscopy under partially denaturing conditions revealed that the two molecules appeared to be joined at a single locus towards their 5' ends ( 1 , 2 ). Various structures have been suggested for the bonding between the two molecules ( 3 - 18 ), but as yet there is no definitive proof of a conserved mechanism among the retroviridae.

The exact role played by dimerisation of genomic RNA in the retrovirus life cycle is unclear, but there is evidence for its potential involvement in recombination, packaging of the viral genome and maturation of the virion ( 19 - 21 ). In almost all instances, retroviral dimer linkage sites have been mapped to a region near to or within that of the packaging signal or [psi] ( 10 , 22 , 23 ). Retroviral dimer formation therefore constitutes a potential antiviral target.

HTLV-1, a type C retrovirus, is the aetiologic agent of both adult T cell lymphoma (ATL) and human T cell leukaemia virus- associated myelopathy/tropical spastic paraparesis (HAM/TSP). Due to the high degree of sequence conservation in the HTLV-1 genome, it represents a good model for in vitro studies of dimerisation. In addition, since it is transmitted by cell-cell interactions, it may help elucidate the role of RNA dimers in this process.

We studied dimerisation in vitro using a 531 bp insert containing sequences up- and downstream of the major splice donor in HTLV-1. This region dimerised readily, the molecules dissociating at temperatures similar to those demonstrated by virion-derived RNA in other systems ( 24 ).

Physical and chemical conditions required for dimer formation were studied and the system optimised to generate reproducibly stable dimerisation. Deletion and site-directed mutagenesis were employed to map the site necessary for RNA interaction and the localisation was compared with secondary structure models derived from computer predictions and analysis of the identified sequence.

MATERIALS AND METHODS

Plasmid construction

Plasmid pGEM11[Delta]LTR2 was constructed by insertion of nt 297-828 from HTLV-1 CH ( 25 , 26 ; numbering according to Seiki et al .; 27 ) into a pGEM11Zf+ vector (Promega) (Fig. 1 a). In this vector, sense transcripts are generated using an SP6 promoter.


Figure 1 . ( a ) Position of the 531 bp insert in the HTLV-1 genome. The restriction enzyme Nhe I linearises the plasmid at 828 and Hin dIII linearises it at 297. ( b ) HTLV-1 transcripts analysed on a non-denaturing 2% agarose-TBE gel. Lane 1, RNA following dilution in dimer buffer and incubation at 37oC for 60 min. Lanes 2-5, RNA incubated for 3 min at the temperatures indicated and then 60 min at 37oC. Dimer (D) and monomer (M) bands indicated. ( c ) Full-length transcript transcribed in the presence and absence of a heterologous RNA. Lanes 1 and 4, HTLV-1 transcript; lanes 2 and 5, heterologous RNA transcript; lanes 3 and 6, both the heterologous RNA and the HTLV-1 transcript transcribed together. Arrows indicate the HTLV-1 dimer (lane 4) and the heterologous RNA monomeric band (lane 2). Lanes 1-3, short exposure; lanes 4-6, long exposure.

In vitro synthesis of RNA

For full-length sense transcripts, plasmids were linearised with Nhe I (Boehringer Mannheim) and the template was prepared by proteinase K digestion followed by phenol/chloroform extraction and ethanol precipitation. In vitro transcription was carried out using the Promega Riboprobe system. The transcripts were cleaned as in the manufacturer's instructions and resuspended in diethyl pyrocarbonate (DEPC)-treated water. Labelled RNA was prepared incorporating [[alpha]- 32 P]GTP (3000 Ci/mmol; NEN, Dupont) or [[alpha]- 32 P]UTP (800 Ci/mmol; NEN, Dupont).

Dimerisation assay

RNA was diluted 1:5 in buffer D (250 mM cacodylic acid, 40 mM KCl, 5 mM MgCl 2 ). The dissociation temperature was determined by heating aliquots of the RNA at a range of temperatures for 3 min and running the products on a 2% non-denaturing agarose gel. The gels were fixed, subjected to autoradiography and the radioactivity counted by real time analysis with an Instant Imager (Packard). To test the stability of the dimer, RNA was heated at each temperature for 3 min, before allowing time for dimers to reform by incubating at 37oC for 60 min.

Plasmid pST8+ was used to produce heterologous RNA for control experiments. It contains a cDNA copy of the influenza virus strain A/PR8/34 segment 8 downstream of an SP6 promoter and flanked by the 5' and 3' untranslated regions from the Xenopus [beta]-globin gene ( 28 ). The plasmid was linearised using Xba I (Boehringer Mannheim). In vitro transcription using this template and/or the HTLV-1 pGEM11[Delta]LTR2 template was performed as described before using SP6 polymerase. The RNA was cleaned as described previously. Plasmid pST 8+ generates an 850 nt transcript and any heterodimers that formed would be expected to run as a band of ~1381 nt. RNA was diluted 1:5 in dimer buffer and run out on a 1% TBE-agarose gel.

In order to investigate the effect of cations on dimerisation, increasing concentrations of the cation to be investigated were incorporated into buffer D in place of the 40 mM KCl. The RNA was dissociated at 80oC for 3 min and allowed to reform dimers as before. Stability of the dimer under denaturing conditions was investigated by running the RNA out on a 2% denaturing gel (2% agarose, 20% formaldehyde). Antisense transcripts were generated by linearising the parent plasmid with Hin dIII (Boehringer Mannheim), preparing the template as before and carrying out the in vitro transcription using a T7 promoter.

Mutagenesis

Restriction enzymes were used to generate 3' end deletions. Bgl I (New England Biolabs) generated a 363 nt transcript, Rsa I (Boehringer Mannheim) generated a 384 nt transcript and Avr II (New England Biolabs) generated a 498 nt transcript. Transcripts were diluted as described above and run out on 2% gels heated (80oC, 3 min) or unheated to determine whether or not they formed dimers.

Internal deletion and site-directed mutagenesis was performed by the Kunkel methodology ( 29 ). RNA was prepared as described previously and dissociation temperature experiments carried out in order to assess the relative stability of the dimers formed. Mutants were sequenced for verification using the Sequenase Version 2.0 DNA sequencing system (United States Biochemical) on 6% acrylamide gels (National Diagnostics).

Computer modelling

Free energy minimisation studies of the 531 nt transcript were carried out by folding overlapping windows of 200 bases. The programs employed were MFOLD, adapted for GCG (Genetics Computer Group, University of Wisconsin, WI) ( 30 , 31 ), with the graphical presentation of Squiggles ( 32 ) in the GCG program PLOTFOLD, as well as STAR ( 33 ).

RESULTS

Dimer formation by HTLV-1 transcripts

The full-length 531 nt RNA transcript formed dimers and monomers following in vitro transcription (Fig. 1 b, lane 1), which could be fully dissociated by heating at 80oC for 3 min (Fig. 1 b, lane 5). Incubation of the HTLV-1 transcript with a heterologous transcript was carried out to test the specificity of the interaction. The heterologous influenza virus transcript did not form homodimers (Fig. 1 c, lanes 2 and 5), neither did it form heterodimers with the HTLV-1 transcript (Fig. 1 c, lanes 3 and 6), testifying to the specificity of the interaction we observed.

Following dissociation at 80oC for 3 min, the dimers would reform only after incubation at 37oC for 60 min in the presence of high sodium or potassium ion concentrations (data not shown). However, the ionic concentration required (>1 M) was not consistent with the guanine tetrad model as proposed for HIV-1 ( 3 , 15 ).

On 2% agarose gels containing formaldehyde, the RNA maintained dimeric mobility, indicating that Watson-Crick base pairing is not the sole interaction involved in the formation of HTLV-1 RNA dimers (data not shown). This is in agreement with investigators studying dimerisation of HIV-1 RNA ( 15 ). Antisense transcripts were generated by linearising the plasmid with Hin dIII and using T7 polymerase. The 531 nt antisense transcript formed dimers to a greatly reduced extent (Fig. 2 ).


Figure 2 . The HTLV-1 transcript forms dimers to a greatly reduced extent in the antisense. Percentage dimer present plotted versus dissociation temperature. Solid line, sense transcript; dotted line, antisense transcript.

Deletion mutagenesis

A series of 3' end deletions defined a 114 nt region essential for the RNA to form dimers (Fig. 3 a). Bgl I generated a 363 nt transcript and Rsa I generated a 384 nt transcript, both of which failed to form dimers (Fig. 3 b, lanes 1 and 8 respectively). Avr II generated a 498 nt transcript which did dimerise (Fig. 3 b, lane 10), thus localising the dimer linkage site to a region between nt 681 and 795. A series of sequential deletions of ~30 nt was designed and introduced into the full-length template (Fig. 4 a). DM1, DM3 and DM4 formed dimers to the same extent as the unmutated HTLV-1 transcript, however, the DM2 deletion virtually abolished dimer formation (Fig. 4 b, lane 2). A key sequence was therefore identified between nt 718 and 749, upon which dimer formation appeared to depend.


Figure 3 . ( a ) 3'-end deletions using restriction enzyme sites. The resulting transcripts were tested in the in vitro dimerisation assay. ( b ) Bgl I (lanes 1 and 2), Rsa I (lanes 7 and 8) and Avr II (lanes 9 and 10) truncations respectively run alongside native HTLV-1 transcripts, heated and unheated, on non-denaturing 2% agarose-TBE gels.


Figure 4 . ( a ) 30 bp deletions across the identified region. Mutant templates were generated using Kunkel mutagenesis, RNA was prepared and the transcripts tested in the in vitro dimerisation assay. ( b ) RNA transcripts prepared from the mutant templates run side by side with the native HTLV-1 transcript on a non-denaturing 2% agarose-TBE gel. Lane 1, DM1 deletion; lane 2, DM2 deletion; lane 3, DM3 deletion; lane 4, DM4 deletion; lane 5, unmutated HTLV-1 transcript.

Computer modelling

We went on to examine the sequence we had located by both computer aided prediction of potential secondary structures and by introduction of point mutations to test these predictions, as well as models suggested by our own sequence analysis.

Nucleic acid folding programs MFOLD and STAR predicted a small stem-loop structure between bases 732 and 744. The stem-loop spanned the region identified as essential for RNA dimerisation by mutagenesis. This is a small but conserved structure, the stem of which was conserved among all HTLV-1 sequences we examined ( 25 , 26 , 34 ) (Fig. 5 a).

Observation also revealed the presence of a palindromic sequence (nt 730-744; see Fig. 5 b) which would have the potential to form a stable base paired link between two RNA molecules, analogous to the model proposed for dimer initiation in HIV-1 ( 12 ).

Site-directed mutagenesis

A series of mutants (L1-L12) which would disrupt the stem-loop structure and additional compensatory mutants (L5C-L7C) were made which probed within the region deleted by DM2 (Table 1 ). The percentage of dimer formed initially and the stability of the dimers at various temperatures was examined for each of the mutants and compared with the unmutated HTLV-1 template. Mutants L1 and L3, which changed bases within the loop of the structure identified by computer modelling, had little or no effect on dimer formation, whereas mutants L2 and L4-L8 all showed some reduction. This appeared to support the stem-loop structure. However, the compensatory mutants L5C, 6C, 7C, 9 and 10 also reduced dimer formation, implying that the stem structure alone was not important for dimer formation. Mutants L11 and 12 were designed to introduce compensatory changes with adenine and uracil bases, but also reduced dimer formation.


Table 1 Site-directed mutagenesis of the 32 bp sequence Mutant templates prepared using Kunkel mutagenesis. RNA transcribed in vitro , then run out on non-denaturing 2% agarose gels. The relative amounts of dimer formed were compared with that of the native transcript for each mutant. HTLV-1 sequence from 718-749 shown together with the substitutions introduced by mutations L1-L12. The sequence forming a putative stem-loop (Fig. 5a) is underlined and the sequence which is palindromic (Fig. 5b) is boxed. The effects of disruptive mutations on interstrand base pairing in the palindromic model are shown in column 3.

The number of base pairing changes which would be introduced into the palindrome model by the mutagenesis are detailed in Table 1 , column 3. Mutant L6C, which introduces C:C and G:A mismatches in place of G:C and A:U pairings, showed a decrease in dimer formation of 89% compared with the native transcript, suggesting that base pairing is important. However, L3 (for example) also introduces four base pair mismatches, incorporating unfavourable C:C and U:U bonds, and this mutant dimerises nearly as well as the unmutated transcript. The data shows a tendency to more pronounced inhibition of dimerisation when putative Watson-Crick pairing in the outer half of the palindrome is disrupted. However, even this is not consistent, as L7 shows a severe phenotype but does not affect a Watson-Crick pair. Even so, disruption of the palindrome does appear to affect dimerisation, since most of the mutations reduced dimer formation.


Figure 5 . ( a ) RNA secondary structures for HTLV-1 CH (25,26), HTLV-1 HCT (34) and HTLV-1 ATK (34) predicted by the MFOLD (all three) and STAR (HTLV-1 CH only) programs. ( b ) Palindromic sequence from 730 to 744.


DISCUSSION

A 32 nt sequence has been identified which is essential for dimerisation of HTLV-1 RNA transcripts in an in vitro assay system. This sequence lies downstream of the major splice donor and just upstream of the primer binding site. In the closely related retrovirus bovine leukaemia virus (BLV), the dimer linkage site has been defined as a 129 nt sequence lying downstream of the splice donor and including the primer binding site ( 22 , 23 , 35 ). In addition, this sequence overlaps with the primary packaging signal of BLV ( 23 ). As yet the packaging signal of HTLV-1 has not been mapped.

Earlier work on RNA dimerisation in HIV-1 ( 3 , 15 ) suggested that guanine tetrads might be involved in dimer formation in a manner comparable with that detected in telomeres. This was based largely on the findings that dimer formation of in vitro transcripts of HIV-1 RNA were stabilised by potassium ions and that dimer formation was disrupted by substitution of guanine residues by other bases ( 15 ). The finding in our study that only very high, non-physiological concentrations of cations stabilised HTLV-1 dimer formation does not support this mechanism in this retrovirus. In addition, deletion of the primer binding site, which contains a sequence of five consecutive guanines, had no effect on dimer formation.

We also examined the possibility that Watson-Crick base pairing might play a role in the formation of RNA dimers. In agreement with other reports ( 15 ), we found little evidence for this, since our transcripts were remarkably stable under denaturing conditions and failed to form significant amounts of dimer in antisense. However, as discussed below, a palindromic sequence is contained within the region we have identified as essential for dimerisation in our system and so we cannot rule out the involvement of Watson-Crick base pairing altogether.

Deletions from the 3' end of the insert identified a 114 nt region which was essential for dimerisation of the RNA transcripts. Of the sequential 30 bp deletions which were made across this portion of the sequence, three of the deletions had no effect on dimer formation. The DM2 deletion, however, which deletes a sequence just upstream of the primer binding site, almost completely prevented dimer formation.

Computer modelling of the entire 531 nt sequence identified a small stem-loop structure conserved amongst all the predicted foldings, spanning the 32 nt region determined by mutagenesis to be essential for RNA dimer formation. Minor variations in the loop did not affect dimer formation, however, the importance of the structure in dimer formation was not supported by results of site-directed mutagenesis directed at changing bases on either side of the stem.

The whole 531 bp HTLV-1 insert was searched using FASTA and BLAST searches for homologies to palindromic sequences described recently in the literature as being required for RNA dimer formation in HIV-1 and MoMuLV ( 7 - 9 , 12 , 14 ). No homologies were found to these sequences. However, the 32 nt sequence identified is highly palindromic and it is possible that sequence, rather than secondary structure, is crucial to the interaction observed here. In addition to the secondary structure identified by the computer predictions, we detected a 15 base palindromic sequence spanning from nt 730 to 744. This interaction was disrupted by site-directed mutagenesis, however, the results did not support interstrand complementarity from base pairs in this palindrome as the major RNA linkage. Some mutations caused major disruption of dimerisation while others had little effect. There was a tendency for mutations disrupting base pairing at the outer halves of the palindrome to have a more pronounced effect.

In conclusion, a 32 nt sequence located at the 5' end of the HTLV-1 genome has been identified which appears to be necessary for dimerisation of RNA transcripts. We cannot conclude from our data that this sequence would be sufficient for dimerisation of full-length genomic RNA, however, we intend to address this question. Although the mechanism by which dimeric transcripts form has yet to be fully elucidated, it is clear that guanine tetrads are not involved and that Watson-Crick base pairing is not the sole interaction. Predicted secondary structures, though formed by conserved sequences, also appear unlikely to be involved. We have observed a palindromic sequence which might be involved in the dimerisation process, although not as the sole interaction. The nature of the dimer linkage structure remains unclear, although a site for the interaction has been defined in HTLV-1. As no current nucleotide interaction model fits the physical characterisation of this interstrand pairing it must be assumed that the linkage, which forms in the complete absence of protein, is a novel structure. Further work is under way to distinguish the precise nucleotides in the dimer linkage and to examine the affect of the DM2 deletion in the context of an infectious molecular clone.

ACKNOWLEDGEMENTS

We thank Dr Paul Digard for the gift of plasmid pST8+, Dr Edwin Ten Dam for helpful suggestions and Teresa Barnes for secretarial assistance.

REFERENCES

1 Bender,W., Chien,Y.-H., Chattopadhyay,S., Vogt,P.K., Gardner,M.B. and Davidson,N. (1978) J. Virol., 25, 888-896. MEDLINE Abstract

2 Murti,K.G., Bondurant,M. and Tereba,A. (1981) J. Virol., 37, 411-419. MEDLINE Abstract

3 Awang,G. and Sen,D. (1993) Biochemistry, 32, 11453-11457. MEDLINE Abstract

4 Berkhout,B., Oude Essink,B.B. and Schoneveld,I. (1993) FASEB J., 7, 181-187. MEDLINE Abstract

5 Darlix,J.-L., Gabus,C. and Allain,B. (1992) J. Virol., 66, 7245-7252. MEDLINE Abstract

6 Feng,Y.-X., Fu,W., Winter,A.J., Levin,J.G. and Rein,A. (1995) J. Virol., 69, 2486-2490. MEDLINE Abstract

7 Girard,P.-M., Bonnet-Mathoniere,B., Muriaux,D. and Paoletti,J. (1995) Biochemistry, 34, 9785-9794. MEDLINE Abstract

8 Laughrea,M. and Jette,L. (1994) Biochemistry, 33, 13464-13474. MEDLINE Abstract

9 Laughrea,M. and Jette,L. (1996) Biochemistry, 35, 1589-1598. MEDLINE Abstract

10 Marquet,R., Baudin,F., Gabus,C., Darlix,J.-L., Mougel,M. Ehresmann,C. and Ehresmann,B. (1991) Nucleic. Acids. Res., 19, 2349-2357. MEDLINE Abstract

11 Marquet,R., Paillart,J.-C., Skripkin,E., Ehresmann,C. and Ehresmann,B. (1994) Nucleic Acids Res., 22, 145-151. MEDLINE Abstract

12 Muriaux,D., Girard,P.-M., Bonnet-Mathoniere,B. and Paoletti,J. (1995) J. Biol. Chem., 270, 8209-8216. MEDLINE Abstract

13 Paillart,J.-C., Marquet,R., Skripkin,E., Ehresmann,B. and Ehresmann,C. (1994) J. Biol. Chem., 269, 27486-27493. MEDLINE Abstract

14 Skripkin,E., Paillart,J.-C., Marquet,R., Ehresmann,B. and Ehresmann,C. (1994) Proc. Natl. Acad. Sci. USA, 91, 4945-4949. MEDLINE Abstract

15 Sundquist,W.I. and Heaphy,S. (1993) Proc. Natl. Acad. Sci. USA, 90, 3393-3397. MEDLINE Abstract

16 Torrent,C., Gabus,C. and Darlix,J.-L. (1994) J. Virol., 68, 661-667. MEDLINE Abstract

17 Tournekti,N., Mougel,M., Roy,C., Marquet,R., Darlix,J.-L., Paoletti,J., Ehresmann,B. and Ehresmann,C. (1992) J. Mol. Biol., 223, 205-220. MEDLINE Abstract

18 Weiss,S., Hausl,G., Famulok,M. and Konig,B. (1993) Nucleic Acids Res., 21, 4879-4885. MEDLINE Abstract

19 Baudin,F., Marquet,R., Isel,C., Darlix,J.-L., Ehresmann,B. and Ehresmann,C. (1993) J. Mol. Biol., 229, 382-397. MEDLINE Abstract

20 Fu,W. and Rein,A. (1993) J. Virol., 67, 5443-5449. MEDLINE Abstract

21 Tchenio,T. and Heidmann,T. (1995) J. Virol., 69, 1079-1084. MEDLINE Abstract

22 Katoh,I., Shisuo,T., Iwakura,Y. and Shibuta,H. (1991) J. Virol., 65, 6845-6855. MEDLINE Abstract

23 Mansky,L.M., Krueger,A.E. and Temin,H.M. (1995) J. Virol., 69, 3282-3289. MEDLINE Abstract

24 Roy,C., Tournekti,N., Mougel,M., Darlix,J.-L., Paoletti,C., Ehresmann,C., Ehresmann,B. and Paoletti,J. (1990) Nucleic Acids Res., 18, 7287-7292. MEDLINE Abstract

25 Paine,E., Garcia,J., Philpott,T.C., Shaw,G. and Ratner,L. (1991) Virology, 182, 111-123. MEDLINE Abstract

26 Shaw,G.M., Gonda,M.A., Flickinger,G.M., Hahn,B.H., Gallo,R.C. and Wong-Staal,F. (1984) Proc. Natl. Acad. Sci. USA, 81, 4544-4568. MEDLINE Abstract

27 Seiki,M., Hattori,S., Hirayama,Y. and Yoshida,M. (1983) Proc. Natl. Acad. Sci. USA, 80, 3618-3622. MEDLINE Abstract

28 Digard,P., Owen,T., Blok,V.C., Brown,C.M. and Inglis,S.C. (1989) In Mahy,B.W.J. and Kolakofsky,D. (eds), Genetics and Pathogenicity of Negative Strand Viruses. Elsevier Biomedical Press, Amsterdam. pp. 104-117.

29 Kunkel,T.A., Roberts,J.D. and Zakour,R.A. (1987) Methods Enzymol., 154, 367-382. MEDLINE Abstract

30 Zucker,M. (1989) Science, 244, 48-52. MEDLINE Abstract

31 Jaegar,J.A., Turner,D.H. and Zucker,M. (1989) Proc. Natl. Acad. Sci. USA, 86, 7706-7710. MEDLINE Abstract

32 Osterburg,G. and Sommer,R. (1981) Comput. Prog. Biomed., 13, 101-109.

33 Abrahams,J.P., van den Berg,M., van Batenburg,E. and Pleij,C. (1990) Nucleic Acids Res., 18, 3035-3044. MEDLINE Abstract

34 Ratner,L., Philpott,T. and Trowbridge,D.B. (1991) AIDS Res. Hum. Retroviruses, 7, 923-941. MEDLINE Abstract

35 Katoh,I., Yasunaga,T. and Yoshinaka,Y. (1993) J. Virol., 67, 1830-1839. MEDLINE Abstract


Return

* To whom correspondence should be addressed
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
A. M. G. Dirac, H. Huthoff, J. Kjems, and B. Berkhout
Requirements for RNA heterodimerization of the human immunodeficiency virus type 1 (HIV-1) and HIV-2 genomes
J. Gen. Virol., October 1, 2002; 83(10): 2533 - 2542.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hoeprich and P. Guo
Computer Modeling of Three-dimensional Structure of DNA-packaging RNA (pRNA) Monomer, Dimer, and Hexamer of Phi29 DNA Packaging Motor
J. Biol. Chem., May 31, 2002; 277(23): 20794 - 20803.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-I. Sakuragi, T. Shioda, and A. T. Panganiban
Duplication of the Primary Encapsidation and Dimer Linkage Region of Human Immunodeficiency Virus Type 1 RNA Results in the Appearance of Monomeric RNA in Virions
J. Virol., March 15, 2001; 75(6): 2557 - 2565.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
N. J. Rose, J. H. Richardson, U. Desselberger, and A. M. L. Lever
Virus inactivation in a proportion of human T-cell leukaemia virus type I-infected T-cell clones arises through naturally occurring mutations
J. Gen. Virol., January 1, 2000; 81(1): 97 - 104.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
I. Le Blanc, J. Greatorex, M.-C. Dokhélar, and A. M. L. Lever
A 37 base sequence in the leader region of human T-cell leukaemia virus type I is a high affinity dimerization site but is not essential for virus replication
J. Gen. Virol., January 1, 2000; 81(1): 105 - 108.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Jossinet, J. S. Lodmell, C. Ehresmann, B. Ehresmann, and R. Marquet
Identification of the in Vitro HIV-2/SIV RNA Dimerization Site Reveals Striking Differences with HIV-1
J. Biol. Chem., February 16, 2001; 276(8): 5598 - 5604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Mat-Arip, K. Garver, C. Chen, S. Sheng, Z. Shao, and P. Guo
Three-dimensional Interaction of Phi29 pRNA Dimer Probed by Chemical Modification Interference, Cryo-AFM, and Cross-linking
J. Biol. Chem., August 24, 2001; 276(35): 32575 - 32584.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. G. Dirac, H. Huthoff, J. Kjems, and B. Berkhout
The Dimer Initiation Site Hairpin Mediates Dimerization of the Human Immunodeficiency Virus, Type 2 RNA Genome
J. Biol. Chem., August 17, 2001; 276(34): 32345 - 32352.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (88K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Greatorex, J.
Right arrow Articles by Lever, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greatorex, J.
Right arrow Articles by Lever, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?